autologous adult stem cell therapy (Regenetech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameautologous adult stem cell therapy (Regenetech)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Peripheral blood stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegenetech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegenetech Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A